Drug therapies activating the power of your body
Palatin Technologies develops peptide therapeutics for diseases with significant unmet medical need and commercial potential.
Female Sexual Dysfunction
Bremelanotide is an on-demand treatment for the most common type of female sexual dysfunction.
Improving quality of life for patients with heart failure
Natriuretic peptide mimetics for heart failure, providing increased therapeutic options.
Obesity and Diabetes
Peptide therapeutics to help regulate eating behavior and energy balance, leading to decreased food intake and weight loss.
Status of our clinical and preclinical programs, including bremelanotide for female sexual dysfunction.
The latest news about Palatin, with the full text of press releases issued by Palatin.
Scheduled presentations by Palatin senior management, quarterly calls, scientific presentations and other upcoming events.